Haemonetics Corp. diskutieren
Haemonetics Corp.
WKN: 881782 / Symbol: HAE / Name: Haemonetics / Aktie / Ausrüstung & Versorgung / Mid Cap /
85,50 €
-4,47 %
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $114.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $105.00 to $107.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Intuit Inc. diskutieren